DUBLIN--(BUSINESS WIRE)--Nov 22, 2022--
The "Biophotonics Market, by End Use, by Application, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.
Based on application, market is segmented into see through imaging, inside imaging, spectro molecular, surface imaging, microscopy, light therapy, biosensors, and other analytic sensing. Furthermore, based on end use, biophotonics market is segmented into medical diagnostics, medical therapeutics, test components, and non-medical applications.
Market Dynamics
Based on end use, medical diagnostics accounted for the largest revenue share in the global biophotonics market, followed by medical therapeutics and test components. Among region, North America held dominant position in the global biophotonics market, followed by Europe and Middle East & Africa.
Key features of the study:
Detailed Segmentation:
Global Biophotonics Market, By End Use:
Global Biophotonics Market, By Application:
Global Biophotonics Market, By Region:
Company Profiles
Key Topics Covered:
1. Research Objectives and Assumptions
2. Market Purview
3. Market Dynamics, Regulations, and Trends Analysis
4. Global Biophotonics Market- Impact of Coronavirus (Covid-19) Pandemic
5. Global Biophotonics Market, By End Use, 2017 - 2030, (US$ Million)
6. Global Biophotonics Market, By Application, 2017 - 2030, (US$ Million)
7. Global Biophotonics Market, By Region, 2017 - 2030, (US$ Million)
8. Competitive Landscape
9. Section
For more information about this report visit https://www.researchandmarkets.com/r/jmddyc
View source version on businesswire.com:https://www.businesswire.com/news/home/20221122005568/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH GENERAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 11/22/2022 09:29 AM/DISC: 11/22/2022 09:29 AM
http://www.businesswire.com/news/home/20221122005568/en